Search results

The instrument is designed to measure inelastic neutron scattering, or do neutron spectroscopy.

This month, ANSTO hosted a delegation from the International Partnership for Nuclear Disarmament Verification (IPNDV) as part of the IPNDV’s Plenary meeting in Sydney. The meeting marked the first time Australia has hosted the IPNDV.

ANSTO provides nuclear forensic analysis and advice in support of law enforcement and training to domestic and international partners

New technology is being developed in Sydney to recycle used Personal Protective Equipment (PPE) and turn it into raw materials for 3D printing.

Dr Ceri Brenner appointed new leader of the Centre for Accelerator Science 

Unique opportunity to contribute to the long term conservation of Australia’s most iconic landmark: The Sydney Harbour Bridge.

Measurements of the naturally-occurring radioactive gas radon can be used to accurately categorise the degree of atmospheric mixing.

ANSTO has been awarded an Athena Bronze Institution Award, acknowledging our dedication to improving workplace equality, diversity and inclusion.

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.

ANSTO continues a longstanding, mutually-beneficial research relationship with the University of Wollongong following the signing of a strategic agreement this week.

ANSTO scientists are participating investigators in three new ARC Industrial Transformation Training Centres, recently announced by the Government.

ANSTO conducts and enables research to address some of Australia’s and the world’s most challenging environmental problems.

ANSTO providing support to emergency services, closed to non-essential staff.

A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.